On August 16, 2013 BioPorto A/S published a prospectus in connection with the offer of minimum 40,000,000 and maximum 70,724,526 new shares with pre-emptive subscription rights for existing shareholders of the company, cf. company announcement no. 30 of August 16, 2013.
The subscription period for the offered shares has expired, and BioPorto A/S is able to conclude that the rights issue has been fully subscribed. The number of shares subscribed for by exercise of pre-emptive subscription rights and pursuant to binding subscription undertakings thus exceeds the maximum of 70,724,526 shares comprised by the rights issue.
The remaining shares (i.e. shares that have not been subscribed for by exercise of pre-emptive subscription rights) will be allocated amongst investors and/or guarantors, who have submitted binding subscription undertakings. The allocation will be completed and notified to each investor and/or guarantor, expectedly no later than September 10, 2013, following which payment for the remaining shares shall be effected. Upon full payment the total net gross proceeds will correspond to an amount of DKK 70,724,526.
The rights issue will be completed when the allocation and payment have taken place and the offered shares are registered with the Danish Business Authority, expectedly on September 12, 2013.
“This is an incredibly great support from our shareholders and with a full subscription we can initiate the planned activities to promote sales.” says Peter Mørch Eriksen, CEO.
Yours sincerely
BioPorto A/S
For further information please contact:
Peter Mørch Eriksen, CEO
Christina Thomsen, Investor relations
Tel.: 45 29 00 00, e-mail investor@bioporto.com
